Advertisement Taming China's Clinical Trial 'Dragon' - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More


Taming China’s Clinical Trial ‘Dragon’

With a population in excess of 1.3 billion and low technical costs, China is a highly attractive venue for clinical trials. In this article, current regulations and permit requirements are examined and a transportation case study is presented. Local solutions and important considerations for choosing appropriate “in country” service providers are also discussed.